-
GAAP results: net loss of $2.8 million (attributable to Astrotech Corporation), on revenue of $1.6 million, or $(0.15) per diluted share for the quarter ended March 31, 2014
-
Astrotech Space Operations ("ASO"), the Company's core business, supported the Tracking and Data Relay Satellite System (TDRS-L) mission which launched during the third quarter of fiscal year 2014
- 1st Detect received another key patent during its fiscal year 2014 for the Company's unique ion trap used for chemical analysis and detection, further protecting our ground breaking miniature mass spectrometer technology
AUSTIN, Texas, May 14, 2014 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq:ASTC), a leading provider of commercial aerospace services, today announced financial results for its fiscal year 2014 third quarter ended March 31, 2014.
"Our core satellite processing business, Astrotech Space Operations, had a slow third quarter due to a relatively light launch schedule. However, the 18-month backlog at ASO looks relatively healthy as we continue to attract valued customers by delivering the best satellite processing services in the industry. Additionally, we are very excited about the prospects at 1st Detect now that we have signed our first significant commercial OEM agreement with Rigaku," said Thomas B. Pickens III, Chairman and CEO of Astrotech.
Third Quarter Results
The Company posted a third quarter fiscal year 2014 net loss of $2.8 million, or $(0.15) per diluted share on revenue of $1.6 million compared with a third quarter fiscal year 2013 net loss of $0.1 million, or $(0.01) per diluted share on revenue of $4.6 million.
Update of Ongoing Operations
ASO's 18-month rolling backlog, which includes contractual backlog and scheduled but uncommitted missions was $27.0 million at March 31, 2014. The majority of the revenue at ASO consists of pre-launch satellite processing services, which include hardware launch preparation, advance planning, use of unique satellite preparation facilities and spacecraft checkout, encapsulation, fueling, and transport and design and fabrication of equipment and hardware for space launch activities at our Titusville, Florida and Vandenberg Air Force Base locations.
1st Detect is the leading commercial developer of miniature mass spectrometry technology. We are paving the way with next generation chemical detection instrumentation and we are aggressively pursuing new strategic partnerships as we move to drive a paradigm shift in this marketplace.
Financial Position and Liquidity
Working capital was $(3.9) million as of March 31, 2014, which included $4.6 million in cash and cash equivalents. During the quarter, the Company did not meet its negotiated covenants, for which the Company received a waiver. This was primarily due to the delay of a mission and required the reclassification of our long-term debt to current.
About Astrotech Corporation
Astrotech is one of the first space commerce companies and remains a strong entrepreneurial force in the aerospace industry. We are leaders in identifying, developing and marketing space technology for commercial use. Our ASO business unit serves our government and commercial satellite and spacecraft customers with pre-launch services on the eastern and western range. 1st Detect Corporation is developing what we believe is a breakthrough miniature mass spectrometer, the MMS-1000™, while Astrogenetix, Inc. is a biotechnology company utilizing microgravity as a research platform for drug discovery and development.
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, continued government support and funding for key space programs, product performance and market acceptance of products and services, as well as other risk factors and business considerations described in Astrotech's Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. Astrotech assumes no obligation to update these forward-looking statements.
Tables follow
| ASTROTECH CORPORATION AND SUBSIDIARIES | ||||
| Condensed Consolidated Statements of Operations | ||||
| (In thousands, except per share data) | ||||
|
Three Months Ended March 31, |
Nine Months Ended March 31, |
|||
| 2014 | 2013 | 2014 | 2013 | |
| (unaudited) | (unaudited) | |||
| Revenue | $ 1,556 | $ 4,565 | $ 10,783 | $ 14,815 |
| Cost of revenue | 2,308 | 2,550 | 8,076 | 10,581 |
| Gross profit (loss) | (752) | 2,015 | 2,707 | 4,234 |
| Operating expenses: | ||||
| Selling, general and administrative | 1,593 | 1,758 | 5,540 | 5,341 |
| Research and development | 645 | 459 | 1,801 | 1,494 |
| Total operating expenses | 2,238 | 2,217 | 7,341 | 6,835 |
| Loss from operations | (2,990) | (202) | (4,634) | (2,601) |
| Interest and other expense, net | (61) | (36) | (178) | (121) |
| Loss before income taxes | (3,051) | (238) | (4,812) | (2,722) |
| Income tax expense | (2) | — | (9) | — |
| Net loss | (3,053) | (238) | (4,821) | (2,722) |
| Less: Net loss attributable to noncontrolling interest* | (216) | (125) | (681) | (382) |
| Net loss attributable to Astrotech Corporation | $ (2,837) | $ (113) | $ (4,140) | $ (2,340) |
| Net loss per share attributable to Astrotech Corporation, basic | $ (0.15) | $ (0.01) | $ (0.21) | $ (0.12) |
| Weighted average common shares outstanding, basic | 19,486 | 19,463 | 19,479 | 19,279 |
| Net loss per share attributable to Astrotech Corporation, diluted | $ (0.15) | $ (0.01) | $ (0.21) | $ (0.12) |
| Weighted average common shares outstanding, diluted | 19,486 | 19,463 | 19,479 | 19,279 |
| * Noncontrolling interest resulted from grants of restricted stock in 1st Detect and Astrogenetix to certain employees, officers and directors. Please refer to the March 31, 2014 10-Q filed with the Securities and Exchange Commission for further detail. | ||||
| ASTROTECH CORPORATION AND SUBSIDIARIES | ||
| Condensed Consolidated Balance Sheets | ||
| (In thousands) | ||
|
March 31, 2014 |
June 30, 2013 |
|
| (unaudited) | ||
| Assets | ||
| Cash and cash equivalents | $ 4,552 | $ 5,096 |
| Accounts receivable, net | 2,146 | 5,317 |
| Prepaid expenses and other current assets | 540 | 503 |
| Total current assets | 7,238 | 10,916 |
| Property, plant, and equipment, net | 35,590 | 37,035 |
| Other assets, net | 35 | 51 |
| Total assets | $ 42,863 | $ 48,002 |
| Liabilities and stockholders' equity | ||
| Current liabilities | $ 11,182 | $ 6,609 |
| Long-term liabilities | 401 | 5,913 |
| Stockholders' equity | 31,280 | 35,480 |
| Total liabilities and stockholders' equity | $ 42,863 | $ 48,002 |
| ASTROTECH CORPORATION AND SUBSIDIARIES | ||||
| Unaudited Reconciliation of Non-GAAP Measures | ||||
| (In thousands) | ||||
| Earnings Before Interest, Taxes, Depreciation and Amortization | ||||
|
Three Months Ended March 31, |
Nine Months Ended March 31, |
|||
| 2014 | 2013 | 2014 | 2013 | |
| EBITDA | $ (2,414) | $ 344 | $ (2,868) | $ (981) |
| Depreciation & amortization | 580 | 520 | 1,767 | 1,552 |
| Interest expense | 57 | 62 | 177 | 189 |
| Income tax expense | 2 | — | 9 | — |
| Net loss | (3,053) | (238) | (4,821) | (2,722) |
| Net loss attributable to noncontrolling interest | (216) | (125) | (681) | (382) |
| Net loss attributable to Astrotech Corporation | $ (2,837) | $ (113) | $ (4,140) | $ (2,340) |
| EBITDA (earnings before interest, taxes, depreciation and amortization) is a non-U.S. GAAP financial measure. We included information concerning EBITDA because we use such information when evaluating operating earnings (loss) to better evaluate the underlying performance of the Company. EBITDA does not represent, and should not be considered an alternative to, net income (loss), operating earnings (loss), or cash flow from operations as those terms are defined by U.S. GAAP and does not necessarily indicate whether cash flows will be sufficient to fund cash needs. While EBITDA is frequently used as measures of operations and the ability to meet debt service requirements by other companies, our use of this financial measure is not necessarily comparable to such other similarly titled captions of other companies. | ||||